We found that a better prognosis characterizes CRC showing high CD8+ T-cells density with high SDF-1 tumor expression in contrast to CRC having high CD8+ T-cell density only, most likely due to an effective antigen-specific immune response. The gene discussed is CXCL12; the disease is neoplasm.